Leverone Jason A.
SEC insider (Form 3/4/5 filer). CIK 0001692747. Chief Financial Officer at OnKure Therapeutics, Inc. (OKUR). 18 reported Form 4/5 transactions since Sep 2024; latest on Sep 21, 2026. Located in BOULDER, CO.
Companies Leverone Jason A. has filed insider reports for
- OnKure Therapeutics, Inc. (OKUR): Officer, Chief Financial Officer
Leverone Jason A.
CIK: 0001692747
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
OnKure Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Sep 21, 2026OKUR
OnKure Therapeutics, Inc.
SaleDirect302 shares at avg. $2.97$898.208 - Aug 7, 2026OKUR
OnKure Therapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy)
130.6K shares- - Aug 7, 2026OKUR
OnKure Therapeutics, Inc.
DispositionDirectEmployee Stock Option (right to buy)
130.6K shares- - Aug 7, 2026OKUR
OnKure Therapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy)
5.3K shares- - Aug 7, 2026OKUR
OnKure Therapeutics, Inc.
DispositionDirectEmployee Stock Option (right to buy)
5.3K shares- - Aug 7, 2026OKUR
OnKure Therapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy
5.8K shares- - Aug 7, 2026OKUR
OnKure Therapeutics, Inc.
DispositionDirectEmployee Stock Option (right to buy
5.8K shares- - Aug 7, 2026OKUR
OnKure Therapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy)
50K shares- - Jun 22, 2026OKUR
OnKure Therapeutics, Inc.
SaleDirect303 shares at avg. $4.40$1K - Apr 1, 2026OKUR
OnKure Therapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy)
110K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 21, 2026 | OKUR OnKure Therapeutics, Inc. | Sale | 302 | $2.97 | $898 | Direct |
| Aug 7, 2026 | OKUR OnKure Therapeutics, Inc. | Award Employee Stock Option (right to buy) | 130,611 | - | - | Direct |
| Aug 7, 2026 | OKUR OnKure Therapeutics, Inc. | Disposition Employee Stock Option (right to buy) | 130,611 | - | - | Direct |
| Aug 7, 2026 | OKUR OnKure Therapeutics, Inc. | Award Employee Stock Option (right to buy) | 5,322 | - | - | Direct |
| Aug 7, 2026 | OKUR OnKure Therapeutics, Inc. | Disposition Employee Stock Option (right to buy) | 5,322 | - | - | Direct |
| Aug 7, 2026 | OKUR OnKure Therapeutics, Inc. | Award Employee Stock Option (right to buy | 5,781 | - | - | Direct |
| Aug 7, 2026 | OKUR OnKure Therapeutics, Inc. | Disposition Employee Stock Option (right to buy | 5,781 | - | - | Direct |
| Aug 7, 2026 | OKUR OnKure Therapeutics, Inc. | Award Employee Stock Option (right to buy) | 50,000 | - | - | Direct |
| Jun 22, 2026 | OKUR OnKure Therapeutics, Inc. | Sale | 303 | $4.40 | $1,332 | Direct |
| Apr 1, 2026 | OKUR OnKure Therapeutics, Inc. | Award Employee Stock Option (right to buy) | 110,000 | - | - | Direct |
1-10 of 18 transactions